Detalhe da pesquisa
1.
Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy.
N Engl J Med
; 386(21): 1998-2010, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613022
2.
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Am J Hematol
; 99(2): 254-262, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108611
3.
What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.
Blood
; 138(9): 749-757, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876223
4.
Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes.
Inflamm Res
; 72(8): 1695-1707, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507570
5.
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.
Br J Haematol
; 198(1): 103-113, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277855
6.
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome.
Platelets
; 32(3): 378-382, 2021 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268817
7.
Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse.
Am J Hematol
; 94(10): 1091-1097, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292998
8.
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations.
Br J Haematol
; 186(4): e100-e103, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31016714
9.
Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).
Br J Haematol
; 185(5): 954-957, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407614
10.
Why methylation is not a marker predictive of response to hypomethylating agents.
Haematologica
; 99(4): 613-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24688109
11.
Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions.
Exp Hematol
; 129: 104118, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741607
12.
Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.
Am J Hematol
; 93(5): E120-E123, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29417611
13.
Bone Marrow Microenvironment Involvement in t-MN: Focus on Mesenchymal Stem Cells.
Mediterr J Hematol Infect Dis
; 15(1): e2023055, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705521
14.
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.
Front Oncol
; 12: 871590, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35494081
15.
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis.
Sci Rep
; 12(1): 21231, 2022 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36481766
16.
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression.
Biology (Basel)
; 10(2)2021 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33562056
17.
Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
Cancer Med
; 10(12): 3839-3847, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34042280
18.
Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia.
Leuk Res
; 99: 106462, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33091616
19.
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.
Haematologica
; 99(9): e152-3, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24907359
20.
The Role of Forkhead Box Proteins in Acute Myeloid Leukemia.
Cancers (Basel)
; 11(6)2019 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31234353